Articles

A small study of patients with non–small-cell lung cancer with brain metastasis showed sotorasib had promising efficacy on brain lesions. Read More ›

A recent retrospective analysis of patients with non–small-cell lung cancer harboring KRAS mutations found immune checkpoint inhibitors have benefit in first- and second-line treatment among KRAS subtypes. Read More ›

A large retrospective chart review found a short median progression-free survival in patients with non–small-cell lung cancer harboring the KRAS G12C mutation who were treated with docetaxel with or without ramucirumab. Read More ›

I am pleased to present the April issue of The Oncology Nurse-APN/PA, a journal specifically designed for nurses, navigators, and advanced practice providers who work tirelessly to improve the lives of patients with cancer. Read More ›

The Nellie B. Connally Breast Center at The University of Texas MD Anderson Cancer Center, Houston, is among the largest in the country. MD Anderson’s team of breast cancer oncologists and subspecialists address all diagnoses, medical complications, and symptoms associated with the disease. Read More ›

An analysis from the ARASENS trial showed that the addition of darolutamide to androgen-deprivation therapy and docetaxel significantly improved overall survival in subgroups of patients with metastatic hormone-sensitive prostate cancer with high-volume and high-risk disease, contributing to the evidence that this combination should be considered the new standard of care for this patient population. Read More ›

Numerous changes need to be made to raise public awareness of the fact that drinking alcohol raises the risk for several types of cancer. Read More ›

Columbus, OH—Intentional modifications to diet are being investigated as a strategy to reduce chronic cancer-related fatigue, according to new data published in the journal Nutrition & Cancer by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University Wexner Medical Center. Read More ›

The FDA has issued a final rule intended to ensure patients are better informed about their breast tissue density when undergoing mammography. Read More ›

On January 25, 2023, the American Nurses Foundation (the Foundation) released the findings from a new comprehensive survey of more than 12,500 nurses nationwide as part of the Pulse on the Nation’s Nurses Survey Series. Read More ›